Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | ADC-derived lesion severity as a prognostic marker beyond infarct size in stroke

Fabiano Cavalcante, MD, PhD(c), Amsterdam UMC, Amsterdam, Netherlands, discusses the potential of ADC-derived lesion severity as a prognostic marker beyond infarct size in stroke, highlighting that it may provide additional information on top of lesion size and help explain why lesion volume alone is not a good predictor of patient outcomes. Dr Cavalcante notes that the results of their sub-study of the MR CLEAN-NO IV trial (ISRCTN80619088) show a correlation between the degree of imaging severity on ADC maps and patient outcomes, and suggests that both CT and MRI may be useful in providing more detailed information on lesion severity. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

It’s a very interesting question that actually was a presentation by a student that I had the privilege of supervising in Amsterdam and she actually looked at whether the degree of radiological severity further contributed on top of the lesion size and I think that’s a very interesting question in stroke in general, because we do know that sometimes patients have a large stroke, but the imaging is not completely established and that there might be information included in the imaging data in the ADC or in the CT scans in the form of net water uptake or some other biomarker of radiological severity and not only volume...

It’s a very interesting question that actually was a presentation by a student that I had the privilege of supervising in Amsterdam and she actually looked at whether the degree of radiological severity further contributed on top of the lesion size and I think that’s a very interesting question in stroke in general, because we do know that sometimes patients have a large stroke, but the imaging is not completely established and that there might be information included in the imaging data in the ADC or in the CT scans in the form of net water uptake or some other biomarker of radiological severity and not only volume. And I think especially now with the availability of more AI and faster ways to process imaging data, those might end up becoming clinically useful data points. We are not there yet. The results we did from ADC were actually a sub-study of the MR CLEAN-NO IV trial, and in there we see that there appears to be some correlation between the degree of the imaging severity on the ADC maps but again how to translate that to clinical practice I think is still something to be discussed in the future. I think there’s a bit more research in CT than in MRI but I think both may help explain why lesion volume alone is not a very good predictor of what’s going to happen to the patient. So there’s more than the total lesion volume. There might be some areas of brain that are more severe or less severely affected, and that might be important both to prognosticate outcome, but maybe also as a treatment guiding piece of information.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.